Danaher Corporation (NYSE:DHR – Get Free Report) shares gapped down before the market opened on Tuesday . The stock had previously closed at $201.11, but opened at $168.84. Danaher shares last traded at $177.57, with a volume of 5,422,637 shares trading hands.
Danaher News Roundup
Here are the key news stories impacting Danaher this week:
- Positive Sentiment: Danaher reported Q2 adjusted EPS of $1.94, ahead of the $1.84 consensus, and revenue of about $6.26 billion to $6.27 billion, also topping estimates. The company also boosted its full-year profit forecast, which signals improved earnings power. Danaher Reports Second Quarter 2026 Results
- Neutral Sentiment: The quarter showed solid year-over-year growth, with revenue up 5.5% and earnings rising sharply from the prior year, indicating the business is still expanding despite a tougher operating environment. Conference Call and Press Release
- Negative Sentiment: Shares fell because management cut its 2026 core revenue growth outlook and said biotechnology revenue was weaker than expected, with analysts pointing to “surprisingly soft” bioprocessing sales. That guidance downgrade appears to outweigh the earnings beat for investors. Reuters article on revenue outlook cut
Analyst Upgrades and Downgrades
A number of brokerages recently issued reports on DHR. Argus decreased their target price on shares of Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research report on Friday, April 24th. Barclays reduced their price target on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. Royal Bank Of Canada assumed coverage on shares of Danaher in a report on Thursday, May 14th. They issued an “outperform” rating and a $200.00 price objective for the company. Wolfe Research lowered shares of Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. Finally, Citigroup initiated coverage on Danaher in a report on Tuesday, May 26th. They set a “buy” rating and a $230.00 target price on the stock. One investment analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and a consensus target price of $231.64.
Danaher Trading Down 13.6%
The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The stock has a market capitalization of $122.95 billion, a P/E ratio of 33.56, a PEG ratio of 2.51 and a beta of 0.79. The firm’s 50-day simple moving average is $183.97 and its 200 day simple moving average is $198.04.
Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating the consensus estimate of $1.84 by $0.10. The company had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.11 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The business’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same quarter last year, the firm posted $0.77 EPS. Equities research analysts anticipate that Danaher Corporation will post 8.45 EPS for the current fiscal year.
Danaher Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is presently 30.95%.
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of DHR. Main Street Group LTD acquired a new stake in shares of Danaher during the 1st quarter valued at $25,000. JPL Wealth Management LLC acquired a new position in shares of Danaher in the 3rd quarter worth $25,000. Elevated Capital Advisors LLC acquired a new stake in shares of Danaher during the fourth quarter worth $26,000. WFA of San Diego LLC purchased a new stake in shares of Danaher during the second quarter valued at $26,000. Finally, Hilton Head Capital Partners LLC purchased a new stake in shares of Danaher during the fourth quarter valued at $27,000. Institutional investors own 79.05% of the company’s stock.
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Read More
- Five stocks we like better than Danaher
- 2 ETFs to Access the World’s Best-Performing Stock Markets In 2026
- IREN’s $2.8 Billion AI Contract Haul Changes the Stock’s Story
- Alphabet Is Planning a New AI Chip. Here’s Why It Matters Ahead of Earnings
- Microsoft’s AI Bet Could Rewrite AMD’s Growth Story
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
